Cargando…

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD

Detalles Bibliográficos
Autores principales:	Meijnikman, Abraham S., Bruin, Sjoerd, Groen, Albert K., Nieuwdorp, Max, Herrema, Hilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738936/ https://www.ncbi.nlm.nih.gov/pubmed/33338513 http://dx.doi.org/10.1016/j.jhep.2020.12.007

Ejemplares similares

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
por: Meijnikman, Abraham S., et al.
Publicado: (2022)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
por: Hoozemans, Jacqueline, et al.
Publicado: (2021)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases
por: Teunis, Charlotte, et al.
Publicado: (2022)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
por: Scheithauer, Torsten P. M., et al.
Publicado: (2020)

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
por: Udayappan, Shanthadevi, et al.
Publicado: (2016)

Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgery
por: Lappa, Dimitra, et al.
Publicado: (2023)

NAFLD in normal weight individuals
por: DiStefano, Johanna K., et al.
Publicado: (2022)

Statistical evaluation of diet-microbe associations
por: Zhang, Xiang, et al.
Publicado: (2019)

Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT
por: Husted, Anna Sofie, et al.
Publicado: (2020)

Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis
por: Limon-De La Rosa, Nathaly, et al.
Publicado: (2022)

Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery
por: Guman, M.S.S., et al.
Publicado: (2022)

Shedding light on dark matter – faecal microbiota transplantation in Europe
por: Wortelboer, Koen, et al.
Publicado: (2021)

Expression of SARS‐CoV‐2 entry factors in human oral tissue
por: Sawa, Yoshihiko, et al.
Publicado: (2021)

LOCALIZATION OF THE TIBIAL ENTRY POINT
por: Labronici, Pedro José, et al.
Publicado: (2015)

Prevalence of NAFLD in Healthy and Young Male Individuals
por: Niaz, Asif, et al.
Publicado: (2011)

Intestinal microbial metabolites in human metabolism and type 2 diabetes
por: Herrema, Hilde, et al.
Publicado: (2020)

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
por: Gilijamse, Pim W., et al.
Publicado: (2020)

Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
por: Meissner, Maxi, et al.
Publicado: (2011)

Managing transition. Support for individuals at key point of change
por: van Staa, AnneLoes
Publicado: (2010)

Jain point laparoscopic entry in contraindications of Palmers point
por: Jain, Nutan, et al.
Publicado: (2022)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD
por: Schübel, Ruth, et al.
Publicado: (2019)

Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points
por: Fondevila, Marcos F., et al.
Publicado: (2021)

SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy–July 2020
por: Rueca, Martina, et al.
Publicado: (2021)

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
por: de Jonge, Patrick A., et al.
Publicado: (2022)

ASSESSMENT OF THE EFFECTIVENESS OF RAPID ANTIGEN TESTING AT POINTS OF ENTRY; PAKISTAN COVID-19 POINT OF ENTRY (POE) ANALYSIS
por: Nasir, Z., et al.
Publicado: (2023)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pl70t3a5uea054i2odc82vinpm